Startup · $3.1m raised
Metabolic health monitoring platform combining real-time glucose monitoring with AI-driven insights and coaching
Every investor coverage indicates participated in a round Vively raised.
| Investor | Rounds | Invested |
|---|---|---|
| Archangel Ventures | Seed · Pre-seed | - |
| Bupa Ventures | Seed | - |
Companies Vively acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Michelle Woolhouse | Medical Director | Startup Daily |
| Michael Pang | Founder | SmartCompany, Startup Daily (28 May 2025), Forbes Australia, Startup Daily (22 Dec 2022) |
| Tim Veron | CEO · Founder | SmartCompany, Startup Daily (28 May 2025), Forbes Australia, Startup Daily (22 Dec 2022) |
Stories naming Vively. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vively, founded by triathlete Tim Veron after reversing his pre-diabetes, raised $1.6 million seed funding led by Archangel Ventures with Bupa Ventures, and has partnered with Bupa to make continuous glucose monitoring more affordable.
Archangel Ventures' annual review recounts closing its second fund above $32 million, passing $10 million invested in Australian startups, and portfolio raises by Aerotruth, Bare, Trendspek, Pearler and Vively during 2022.
A year-end roundup listing six recent startup raises, giving amounts, lead investors and co-investors for Tic:Toc, 5B, Syenta, Vively, Aerotruth and Potiki, plus each company's stated plans for the money.